Details for New Drug Application (NDA): 210762
✉ Email this page to a colleague
The generic ingredient in FENTANYL CITRATE PRESERVATIVE FREE is fentanyl citrate. There are thirty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.
Summary for 210762
| Tradename: | FENTANYL CITRATE PRESERVATIVE FREE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | fentanyl citrate |
| Patents: | 0 |
Pharmacology for NDA: 210762
| Mechanism of Action | Full Opioid Agonists |
Suppliers and Packaging for NDA: 210762
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FENTANYL CITRATE PRESERVATIVE FREE | fentanyl citrate | INJECTABLE;INJECTION | 210762 | ANDA | Fresenius Kabi USA, LLC | 63323-806 | 63323-806-01 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-806-11) |
| FENTANYL CITRATE PRESERVATIVE FREE | fentanyl citrate | INJECTABLE;INJECTION | 210762 | ANDA | Fresenius Kabi USA, LLC | 63323-806 | 63323-806-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-806-02) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-806-12) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.05MG BASE/ML | ||||
| Approval Date: | May 3, 2019 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
